821 - 830 of 7939 Results
Title
Year
-
RESTRICTEDTitle: From Lysosomal Storage Disorders to Parkinson’s Disease – Challenges and OpportunitiesJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 435Issue #: 12Start Page: 167932End Page: 167932Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1016/j.jmb.2022.167932Best OA location URL: https://doi.org/10.1016/j.jmb.2022.167932Citation Count: 9
- Multiscale model of primary motor cortex circuits predicts in vivo cell-type-specific, behavioral state-dependent dynamics2023OPENTitle: Multiscale model of primary motor cortex circuits predicts in vivo cell-type-specific, behavioral state-dependent dynamicsJournal Name: Cell ReportsPublisher: Elsevier BVVol: 42Issue #: 6Start Page: 112574End Page: 112574Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1016/j.celrep.2023.112574Best OA location URL: http://www.cell.com/article/S2211124723005855/pdfCitation Count: 14
- Stability Changes in Fall-Prone Individuals With Parkinson Disease Following Reactive Step Training2023RESTRICTEDTitle: Stability Changes in Fall-Prone Individuals With Parkinson Disease Following Reactive Step TrainingJournal Name: Journal of Neurologic Physical TherapyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 48Issue #: 1Start Page: 46End Page: 53Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1097/npt.0000000000000442Citation Count: 7
-
RESTRICTEDTitle: The Endo-lysosomal System in Parkinson’s Disease: Expanding the HorizonJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 435Issue #: 12Start Page: 168140End Page: 168140Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2023.168140Best OA location URL: https://doi.org/10.1016/j.jmb.2023.168140Citation Count: 9
- β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control Study2023OPENTitle: β2-Adrenoceptor Agonists in Asthma or Chronic Obstructive Pulmonary Disease and Risk of Parkinson’s Disease: Nested Case-Control StudyJournal Name: Clinical EpidemiologyPublisher: Informa UK LimitedVol: Volume 15Issue #:Start Page: 695End Page: 705Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.2147/clep.s405325Best OA location URL: https://www.dovepress.com/getfile.php?fileID=90360Citation Count: 1
- Bioinformatics pipeline to guide post‐GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variants2023RESTRICTEDTitle: Bioinformatics pipeline to guide post‐GWAS studies in Alzheimer's: A new catalogue of disease candidate short structural variantsJournal Name: Alzheimer's & DementiaPublisher: WileyVol: 19Issue #: 9Start Page: 4094End Page: 4109Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/alz.13168Citation Count: 1
- PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial Damage2023OPENTitle: PINK1-Dependent Mitophagy Inhibits Elevated Ubiquitin Phosphorylation Caused by Mitochondrial DamageJournal Name: Journal of Medicinal ChemistryPublisher: American Chemical Society (ACS)Vol: 66Issue #: 11Start Page: 7645End Page: 7656Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1021/acs.jmedchem.3c00555Best OA location URL: https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.3c00555Citation Count: 7
-
OPENTitle: The contributions of mitochondrial and nuclear mitochondrial genetic variation to neuroticismJournal Name: Nature CommunicationsPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1038/s41467-023-38480-yBest OA location URL: https://www.nature.com/articles/s41467-023-38480-y.pdfCitation Count: 2
- A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's Disease2023OPENTitle: A Double‐Blind, Randomized, Placebo‐Controlled Trial of Ursodeoxycholic Acid (UDCA) in Parkinson's DiseaseJournal Name: Movement DisordersPublisher: WileyVol: 38Issue #: 8Start Page: 1493End Page: 1502Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.29450Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.29450Citation Count: 16
- Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?2023RESTRICTEDTitle: Alpha synuclein post translational modifications: potential targets for Parkinson’s disease therapy?Journal Name: Frontiers in Molecular NeurosciencePublisher: Frontiers Media SAVol: 16Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnmol.2023.1197853Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnmol.2023.1197853/pdfCitation Count: 5